Acquisition of a Yokogawa CV8000 HCA system to the StemScreen Center for Stem Cell-based Disease Modelling and Drug Screening

Information

15 - Voluntary ex ante transparency notice
Negotiated procedure without prior publication
6/19/2023 9:43 AM (GMT+02:00)

Buyer

University of Copenhagen University of Copenhagen
Susanne Ünsal
krystalgade 25
1172 Copenhagen
Denmark

Assignment text

The product is intended for the Center for Stem Cell-based Disease Modelling and Drug Screening (Stem Screen). The Center includes two Danish biotech firms – Bioneer A/S and Synklino A/S – Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, the Department of Veterinary and Animal Sciences, Department of Drug Design and Pharmacology and Department of Cellular and Molecular Medicine at the University of Copenhagen. Using knowledge of how tissue form and are maintained, as well as how this can be recapitulated in vitro based on stem cell models, the overall aim of the center is to developed new stem cell-based therapeutic approaches. In Stem Screen we will establish the first Danish academic-industrial partnership around stem cell-based disease modeling and drug screening with strong international links.

Mercell Holding AS

Part of the Mercell Group, one of Europe’s leading providers of e tender systems and information between buyers and suppliers in the professional market.

Contact us

Write to us

+47 21 01 88 00